pyridostigmine bromide has been researched along with Acute Confusional Senile Dementia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, RD; Hossain, MS; Parween, F; Singh, KP | 1 |
| Feliciani, C; Gambi, D; Iarlori, C; Reale, M | 1 |
| Adani, R; Amitai, G; Avila, J; Farías, GG; Godoy, JA; Inestrosa, NC; Meshulam, H; Vázquez, MC | 1 |
| Caraceni, T; Cocchi, D; Lamperti, E; Müller, EE; Parati, EA | 1 |
| Lee, JD; Lee, SF; Lin, CH; Liu, WF; Ma, C; Shih, JH | 1 |
5 other study(ies) available for pyridostigmine bromide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
Topics: Alzheimer Disease; Aryldialkylphosphatase; Cholinesterase Inhibitors; Donepezil; Humans; Mutation; Protein Binding; Pyridostigmine Bromide | 2021 |
Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokines; Cholinesterase Inhibitors; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interferon-gamma; Interleukin-4; Male; Mental Status Schedule; Monocytes; Peptide Fragments; Pyridostigmine Bromide; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Reference Values; Up-Regulation | 2008 |
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Brain; Cells, Cultured; Cholinesterase Inhibitors; Cytoskeletal Proteins; Disease Models, Animal; Down-Regulation; Drug Compounding; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ibuprofen; Intercellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Pyridinium Compounds; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Signal Transduction; Trans-Activators; Wnt Proteins | 2005 |
Growth hormone responses to cholinergically active drugs in patients with dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Atropine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pyridostigmine Bromide; Radioimmunoassay; Time Factors | 1992 |
Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats.
Topics: Administration, Oral; Alzheimer Disease; Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Reinforcement Schedule | 1991 |